A discovery from Australian researchers could lead to better treatment for children with neuroblastoma, a cancer that ...

Professor Peter Johnson, NHS National Clinical Director for Cancer, said: “This cutting-edge therapy has shown real promise in trials and could give patients with this aggressive form of leukaemia a ...

A new immunotherapy for leukaemia will soon be available on the NHS, offering hope to adults whose disease has returned or ...

Family claims administrators at Hawaiʻi's only public psychiatric hospital failed to institute basic safety protocols to ...

Acute myeloid leukemia symptoms include severe fatigue, shortness of breath and unusual bleeding, as highlighted by Tatiana ...

MONDAY, Nov. 17, 2025 (HealthDay News) — Thyroid cancer is often a highly treatable disease. Most cases are detected in early ...

Imagine a cancer so aggressive that even after intensive surgery, radiation, and chemotherapy, nearly 90 percent of patients ...

A collaborative research team, led by scientists at VCU Massey Comprehensive Cancer Center and Huntsman Cancer Institute at ...

Curasight A/S ("Curasight" or "the Company" (CPH: CURAS), a clinical stage radiopharmaceuticals company, today announced its phase 1 trial investigating uTREAT® in aggressive brain cancer is now open ...

Cancer patients, oncologists and advocates tell Rhian Lubin why the US health insurance system needs urgent reform, and is ...

Minimally invasive dentistry is more than new tech; it’s a shift from 'drill and fill' to a philosophy of prevention and ...

Today, a new approach is giving patients and their physicians reason to hope. Moffitt Cancer Center has expanded its ...